Cell Proliferation in the Evaluation of Carcinogenic Risk and the Inadequacies of the Initiation-Promotion Model

Abstract

References

Armitage, P.

, and

R. Doll.

1954. The age distribution of cancer and a multistage theory of carcinogenesis. Br. J. Cancer 8:1-12.

Astrup, E.G.

, and

O.H. Iversen.

1983. The tumourigenic and carcinogenic effect of 12-0-tetradecanoylphorbol-13-acetate when applied to the skin of BALB/cA and hairless (hr/hr) mice. Acta. Path. Microbiol. Immunol. Scand. (Sect A) 91:103-113.

Auerbach, O.

, and

L. Garfinkel.

1989. Histologic changes in the urinary bladder in relation to cigarette smoking and use of artificial sweeteners. Cancer (Phila.) 64:983-987.

Berenblum, I.

, and

P. Shubik.

1947. A new quantitative approach to the study of the stages of chemical carcinogenesis in the mouse's skin. Br. J. Cancer 1:384-391.

Bishop, J.M.

1991. Molecular themes in oncogenesis. Cell 64:235-248.

Boutwell, R.K.

1964. Some biological aspects of skin carcinogenesis . Progr. Exp. Tumor. Res. 4:207-250.

Boveri, T.

1914. Zur Trage der entstehung maligner Tumoren. Jena, Germany: G. Fisher.

Cohen, S.M.

1997. The role of cell proliferation in the etiology of neoplasia . In Chemical carcinogens and anticarcinogens , eds.

G. T. Bowden

and

S. M. Fisher

, 401-424. Amsterdam: Pergamon .

Cohen, S.M.

, and

L.B. Ellwein.

1990. Cell proliferation in carcinogenesis . Science 249:1007-1011.

10.

Cohen, S.M.

, and

L.B. Ellwein.

1991. Genetic errors, cell proliferation, and carcinogenesis. Cancer Res. 51:6493-6505.

11.

Cohen, S.M.

, and

L.B. Ellwein.

1992. Risk assessment based on high-dose animal exposure experiments. Chem. Res. Toxicol. 5:742-748.

12.

Cohen, S.M.

L.B. Ellwein

T. Okamura

T. Masui

S.L. Johansson

R.A. Smith

J.M. Wehner

M. Khaehab

C.I. Chappel

, and

G.P. Schoenig.

1991a. Comparative bladder tumor promoting activity of sodium saccharin, sodium ascorbate, related acids, and calcium salts in rats. Cancer Res. 51:1766-1777.

13.

Cohen, S.M.

J.B. Jacobs

M. Arai

, and

G.H. Friedell.

1979. Promoting effect of saccharin and DL-tryptophan in urinary bladder carcinogenesis. Cancer Res. 39:1207-1217.

14.

Cohen, S.M.

D.T. Purtilo

, and

L.B. Ellwein.

1991b. Pivotal role of increased cell proliferation in human carcinogenesis. Modern Pathol. 4:371-482.

15.

Damjanov, I., and J. Linder. (ed.) 1996. Anderson's pathology, Tenth Edition, Vol. I & II. St. Louis, MO: C. V Mosby.

16.

Ellwein, L.B.

, and

S.M. Cohen.

1992. Simulation modeling of carcinogenesis . Toxicol. Appl. Pharmacol. 113:98-108.

17.

Fukushima, S.

K. Imaida

T. Sakata

T. Okamura

M. Shibata

, and

N. Ito.

1983. Promoting effects of sodium L-ascorbate on 2-stage urinary bladder carcinogenesis in rats. Cancer Res. 43:4454-4457.

18.

Goerttler, K.L.

, and

H. Loehrke.

1976. Improved tumor yields by means by TPA-DMBA-TPA variation of the Berenblum-Mottram experiment on the back skin of NMRI mice . The effect of stationary hyperplasia without inflammation. Exp. Path. B 12:S336-S341.

19.

Greenfield, R.E.

L.B. Ellwein

, and

S.M. Cohen.

1984. A general probabilistic model of carcinogenesis: Analysis of experimental urinary bladder cancer. Carcinogenesis 5:437-445.

20.

Harris, C.C.

1985. Future directions in the use of DNA adducts as internal dosimeters for monitoring human exposure to environmental mutagens and carcinogens . Environ. Hlth. Perspect. 62:185-191.

21.

Hasegawa, R.

R.E. Greenfield

G. Murasaki

T. Suzuki

, and

S.M. Cohen.

1985. Initiation of urinary bladder carcinogenesis in rats by freeze ulceration with sodium saccharin promotion. Cancer Res. 45:1469-1473.

22.

Hasegawa, R.

M.K. St. John

M. Cano

P. Issenberg

D.A. Klein

B.A. Walker

J.W. Jones

R.C. Schnell

B.A. Merrick

, and

M.H. Davies.

1984. Bladder freeze ulceration and sodium saccharin feeding in the rat: Examination of urinary nitrosamines mutagens and bacteria and effect on hepatic microsomal enzymes. Food Chem Toxicol. 22:935-942.

23.

Ito, N.

, and

M. Hirose.

1990. Antioxidants-carcinogenic and chemopreventive properties. Adv. Cancer Res. 53:247-302.

24.

Ito, N.

K. Imaida

R. Hasegawa

, and

H. Tsuda.

1989. Rapid bioassay methods for carcinogens and modifiers of hepatocarcinogenesis. CRC Crit. Rev. Toxicol . 19:385-415.

25.

Klein-Szanto, A.J.P.

1984. Morphological evaluation of tumor promoter effects on mammalian skin. Mechanisms of tumor promotion, Vol. II, ed. T. J. Slaga, 41-72. Boca Raton, FL: CRC Press.

26.

Knudson, A.G., Jr.

1971. Mutation and cancer: Statistical study of retinoblastoma . Proc. Natl. Acad. Sci. USA 68:820-823.

27.

Moolgavkar, S.H.

, and

A.G. Knudson, Jr.

1981. Mutation and cancer: A model for human carcinogenesis. J. Natl. Cancer. Inst. 66:1037-1052.

28.

Murasaki, G.

, and

S.M. Cohen.

1983a. Co-carcinogenicity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide for the urinary bladder . Carcinogenesis 4:97-99.

29.

Murasaki, G.

, and

S.M. Cohen.

1983b. Effect of sodium saccharin on urinary bladder epithelial regenerative hyperplasia following freeze ulceration. Cancer Res. 43:182-187.

30.

Nakanishi, K.

A. Hagawara

M. Shibata

K. Imaida

M. Tatematsu

, and

N. Ito.

1980. Dose-response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)-nitrosamine . J. Natl. Cancer Inst. 65:1005-1010.

31.

O'Connell, J.F.

J.B. Rotstein

, and

T.J. Slaga.

1987. Tumor promotion and progression in the mouse skin model. Banbury Rep. 25:11-23.

32.

Peraino, C.

1981. Initiation and promotion of liver tumorigenesis . Natl. Cancer. Inst. Monogr. 58:55-61.

33.

Peraino, C.

R.J.M. Fry

, and

E. Staffeldt.

1971. Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced by the rat by 2-acetylaminofluorene. Cancer Res. 31:1506-1512.

34.

Pitot, H.C.

1989. Progression: The terminal stage in carcinogenesis. Jpn . J. Cancer Res. 80:599-607.

35.

Portier, C.J.

, and

L. Edler.

1990. Two-stage models of carcinogenesis, classification of agents, and design of experiments. Fund. Appl. Toxicol. 14:444-460.

36.

Preston-Martin, S.

M.C. Pike

R.K. Ross

P.A. Jones

, and

B.E. Henderson.

1990. Increased cell division as a cause of human cancer. Cancer Res. 50: 7415-7421.

37.

Reddy, B.S.

C. Burill

, and

J. Rigotty.

1991. Effects of diets high in ω-3 and ω-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis . Cancer Res. 51:487-491.

38.

Reid, T.M.

, and

L.A. Loeb.

1993. Tandem double CC → TT mutations are produced by reactive oxygen species. Proc. Natl. Acad. Sci. USA 90:3904-3907.

39.

Rom, W.N.

W.D. Travis

, and

A.R. Brody.

1991. Cellular and molecular basis of the asbestos-related diseases. Am. Rev. Respir. Dis. 143:408-422.

40.

Schulte-Hermann, R.

I. Timmerman-Trosiener

G. Barthel

, and

W. Bursch.

1990. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res. 50:5127-5135.

41.

Stanbridge, E.J.

1990. Human tumor suppressor genes. Annu. Rev. Genet. 24:615-657.

42.

Takahashi, M.

F. Furukawa

K. Toyoda

H. Sato

R. Hasegawa

K. Imaida

, and

Y. Hayashi.

1990. Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine. Carcinogenesis 11:393-395.

43.

Talaska, G.

A.Z. Al-Juburi

, and

F.F. Kadlubar.

1991. Smoking-related carcinogen-DNA adducts in biopsy samples of human urinary bladder: Identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc. Natl. Acad. Sci. USA 88:5350-5354.

44.

Tatematsu, M.

Y. Miyata

M. Mizutani

M. Hananouchi

M. Hirose

, and

N. Ito.

1977. Summation effect of N-butyl-N-(4-hydroxybutyl)nitrosamine, N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide, N-2-fluorenylacetamide, and 3,3'-dichlorobenzidine on urinary bladder carcinogenesis in rats. Jpn. J. Cancer Res. 68:193-202.

45.

Tatematsu, M.

T. Shirai

K. Ogawa

M. Asamoto

, and

N. Ito.

1991. Proliferation kinetics and development of pepsinogen-altered pyloric gland cells in the glandular stomach of rats treated with chemicals. In Chemical induced cell proliferation: Implications for risk assessment, ed.

B. E. Butterworth

, 445-465. New York: Wiley-Liss .

46.

Tsuda, H.

Y. Miyata

G. Murasaki

H. Kinoshita

S. Fukushima

, and

N. Ito.

1977. Synergistic effect of urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine, N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide, N-2-fluorenylacetamide, and 3,3'-dichlorobenzidine. Jpn. J. Cancer Res. 68:183-192.

47.

Vineis, P.

1995. Tobacco and cancer: An update. Crit. Revs. Oncol. /Hematol. 18:103-110.

48.

Ward, J.M.

1983. Increased susceptibility of livers of aged F344/NCr rats to the effects of phenobarbital on the incidence, morphology, and histochemistry of hepatocellular foci and neoplasms. J. Natl. Cancer Inst . 71:815-823.

49.

Williams, G.M.

1980. Classification of genotoxic and epigenetic hepatocarcinogens using liver culture assays. Ann. NY Acad. Sci. 349:273-282.

50.

World Health Organization.

1993. Electromagnetic fields (300 Hz to 300 GHz). Environmental Health Criteria Series 137.

51.

Yeh, F-S.

M.C. Yu

C-C. Mo

S. Luo

M.J. Tong

, and

B.E. Henderson.

1989. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res. 49:2506-2509.